Q4 2024 Earnings Call Transcript March 20, 2025 Cibus, Inc. misses on earnings expectations. Reported EPS is $-0.87 EPS, expectations were $-0.68. Operator: Good afternoon, and welcome to the Cibus ...

Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...

The company previously announced that the first patient dosed with ECUR-506 for OTC deficiency achieved complete clinical response.

One of the key challenges of the modern genomics era is studying the thousands of genes in a single human cell at scale. To ...

By Deena Beasley (Reuters) -Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing ...

Is immortality achievable? With longevity science booming, you might make it to age 150 — but your portfolio might not.

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

The Chinese scientist who was imprisoned for secretly creating the world’s first genetically-engineered babies has claimed he ...